Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients

Orexa B.V. Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Oregon

View original content:https://www.prnewswire.co.uk/news-releases/orexa-announces-first-patient-dosed-in-phase-2-trial-in-post-operative-patients-302056031.html